يعرض 12,761 - 12,780 نتائج من 19,563 نتيجة بحث عن '(( significant ((gap decrease) OR (a decrease)) ) OR ( significantly increased decrease ))', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 12761

    S1 Raw data - حسب Xiaoyi Shi (3825754)

    منشور في 2024
    "…In contrast, melatonin supplementation blocked the PGAM5-mPTP axis and thus decreased cell death, providing a protective advantage to hepatocytes in I/R. …"
  2. 12762

    The chemical structure of melatonin. حسب Xiaoyi Shi (3825754)

    منشور في 2024
    "…In contrast, melatonin supplementation blocked the PGAM5-mPTP axis and thus decreased cell death, providing a protective advantage to hepatocytes in I/R. …"
  3. 12763
  4. 12764

    S1 File - حسب Kathleen Kristensen (17525457)

    منشور في 2025
    "…., participant reported difficulty in accessing syringes and naloxone) among PWID participating in a longitudinal study conducted through the University of Illinois-Chicago’s Community Outreach Intervention Projects field sites during the COVID-19 pandemic.…"
  5. 12765

    Chicago COVID-19 mitigation policy timeline. حسب Kathleen Kristensen (17525457)

    منشور في 2025
    "…., participant reported difficulty in accessing syringes and naloxone) among PWID participating in a longitudinal study conducted through the University of Illinois-Chicago’s Community Outreach Intervention Projects field sites during the COVID-19 pandemic.…"
  6. 12766

    Micelle and Inverse Micelle Structure Driven Viscoelasticity and Phase Separation in 2‑Isobutoxyethanol–Water Mixtures: Insights from All-Atom Simulations حسب Mayank Dixit (7879364)

    منشور في 2025
    "…Dynamical properties show a pronounced slowdown of IBE self-diffusion with decreasing the mole fraction of 2-isobutoxyethanol (<i>x</i><sub>IBE</sub>). …"
  7. 12767

    Micelle and Inverse Micelle Structure Driven Viscoelasticity and Phase Separation in 2‑Isobutoxyethanol–Water Mixtures: Insights from All-Atom Simulations حسب Mayank Dixit (7879364)

    منشور في 2025
    "…Dynamical properties show a pronounced slowdown of IBE self-diffusion with decreasing the mole fraction of 2-isobutoxyethanol (<i>x</i><sub>IBE</sub>). …"
  8. 12768
  9. 12769
  10. 12770

    Descriptive statistics. حسب Yintu Bao (12113769)

    منشور في 2025
    "…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
  11. 12771

    Variable description. حسب Yintu Bao (12113769)

    منشور في 2025
    "…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
  12. 12772

    Village characteristics. حسب Yintu Bao (12113769)

    منشور في 2025
    "…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
  13. 12773

    Research data 2. حسب Yintu Bao (12113769)

    منشور في 2025
    "…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
  14. 12774
  15. 12775

    Infection of CD 34 حسب Ancy Joseph (5634794)

    منشور في 2025
    "…<p><b>+</b><b> humanized mice resulted in decrease in pathogenicity in CTCF Infected mice.</b> A. …"
  16. 12776

    <b>Distributed Hydraulic Micro-Cooling (MHD): A Low-Cost, High-Impact Urban Heat Mitigation Strategy</b> / <b>Enfriamiento Hidráulico Micro-Distribuido (MHD): Estrategia Urbana de... حسب Ricardo Riveros (22484566)

    منشور في 2025
    "…Large thermal masses such as roofs, asphalt roads, and concrete structures store significant amounts of solar radiation during the day (up to 1200–1600 MJ/m²). …"
  17. 12777

    Image 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

    منشور في 2025
    "…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"
  18. 12778

    Table 3_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

    منشور في 2025
    "…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"
  19. 12779

    Image 2_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

    منشور في 2025
    "…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"
  20. 12780

    Table 7_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

    منشور في 2025
    "…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …"